IFP Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-307
| Closed | -$8.44K | – | 4963 |
|
2025
Q1 | $8.44K | Hold |
307
| – | – | ﹤0.01% | 2640 |
|
2024
Q4 | $8.28K | Hold |
307
| – | – | ﹤0.01% | 2603 |
|
2024
Q3 | $8.85K | Hold |
307
| – | – | ﹤0.01% | 2471 |
|
2024
Q2 | $8.36K | Hold |
307
| – | – | ﹤0.01% | 2403 |
|
2024
Q1 | $8.6K | Hold |
307
| – | – | ﹤0.01% | 2289 |
|
2023
Q4 | $8.17K | Hold |
307
| – | – | ﹤0.01% | 2260 |
|
2023
Q3 | $7.85K | Hold |
307
| – | – | ﹤0.01% | 2347 |
|
2023
Q2 | $8.04K | Hold |
307
| – | – | ﹤0.01% | 2370 |
|
2023
Q1 | $6.6K | Hold |
307
| – | – | ﹤0.01% | 2462 |
|
2022
Q4 | $7K | Hold |
307
| – | – | ﹤0.01% | 3598 |
|
2022
Q3 | $7K | Sell |
307
-285
| -48% | -$6.5K | ﹤0.01% | 3851 |
|
2022
Q2 | $13K | Hold |
592
| – | – | ﹤0.01% | 3187 |
|
2022
Q1 | $13K | Buy |
592
+277
| +88% | +$6.08K | ﹤0.01% | 3187 |
|
2021
Q4 | $9K | Hold |
315
| – | – | ﹤0.01% | 2226 |
|
2021
Q3 | $8K | Hold |
315
| – | – | ﹤0.01% | 2310 |
|
2021
Q2 | $8K | Hold |
315
| – | – | ﹤0.01% | 2282 |
|
2021
Q1 | $8K | Hold |
315
| – | – | ﹤0.01% | 2206 |
|
2020
Q4 | $8K | Hold |
315
| – | – | ﹤0.01% | 2140 |
|
2020
Q3 | $8K | Hold |
315
| – | – | ﹤0.01% | 1973 |
|
2020
Q2 | $7K | Buy |
+315
| New | +$7K | ﹤0.01% | 1933 |
|
2017
Q4 | – | Sell |
-200
| Closed | -$4K | – | 3851 |
|
2017
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 3461 |
|
2017
Q2 | $4K | Hold |
200
| – | – | ﹤0.01% | 3464 |
|
2017
Q1 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 3370 |
|